MedTrace Logo

Caudal Epidural Injection of Dextrose For Low Back Pain

NCT01547364 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2018-04-30

No results posted yet for this study

Summary

Objective: The purposes of the study are to

1. Explore the immediate and short term (to 48 hour) analgesic potential of epidural D5W in comparison to normal saline.
2. Determine if cumulative benefit results from caudal dextrose injection.
3. Evaluate accuracy of a small needle vertical approach caudal injection that will allow for blind injection of D5W.

Conditions

  • Back Pain Lower Back Chronic

Interventions

DRUG

Saline

Injection of 10 ml of normal saline into the caudal epidural space

DRUG

Dextrose

Injection of 10 ml or dextrose 5% in water into the caudal epidural space

Sponsors & Collaborators

  • Smigel, Liza, M.D.

    lead INDIV

Principal Investigators

  • Liza Smigel, M.D. · Liza Smigel, M.D., P.A.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-10-31
Completion
2015-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01547364 on ClinicalTrials.gov